The effects of streptozotocin-induced hypoinsulinemia on serum lipid levels in spontaneously hyperlipidemic rats

Hormone and Metabolic Research

Volumn 29, Issue 9, 1997, Pages 454-457

  Nakura, H ^a   Tanaka, M ^a   Tateishi, T ^a   Watanabe, M ^a   Kumai, T ^a   Kobayashi, S ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Atherogenic index; Cholesterol; HDL; Hyperglycemia; Hyperlipidemia; LDL; Lipoprotein; Streptozotocin

Indexed keywords

CHOLESTEROL; LIPOPROTEIN; STREPTOZOCIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HYPERLIPIDEMIA; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0030680218     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979076     Document Type: Article

References (23)

1. Ahlborg, G. P., L. Felig, R. Hagenfeld, J. W. Hendler: Substrate turn-over during prolonged exercise in man; splanchnic and leg metabolism of glucose, free fatty acid, and amino acids. J Clin Invest 53: 1080-1090 (1974)
2. Anonymous, The Pooling Project Research Group: Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the pooling project. J Chron Dis 31: 201-306 (1978)
3. Kaplan, N. M.: The deadly quartet: upper-body obesity, glucose tolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 149: 1514-1520 (1989)
4. Arbeeny, C. M., K. E. Bergguist: The effect of pravastatin on serum cholesterol levels in hypercholesterolemic diabetic rabbits. Biochem Biophys Acta 1096: 238-244 (1991)
5. Beynen, A. C., M. B. Katan, L. F. M. Van Zutphen, R. Paoletti, D. Kritchevsky (ed.): In: Advances in lipid research. Academic Press Inc, San Diego (1987)
6. Kondo, T., Y. Watanabe: A heritable hyperlipidemic rabbit. Exp Anim 24: 89-94 (1975)
7. Chapman, M. J.: Animal lipoproteins: Chemistry, structure, and comparative aspect. J Lipid Res 21: 789-853 (1980)
8. Tohansson, M. B. N., B. W. Karlsson: Lipoproteins in serum of rat, mouse, gerbil, rabbit, pig and man studied by electrophoretical and immunological methods. Comp Biochem Physiol 54 B: 495-500 (1976)
9. Nakura, H., M. Watanabe, M. Tanaka, T. Kumai, C. Matsumoto, S. Kobayashi: Activities of drug-metabolizing enzymes in the liver of spontaneously hyperlipidemic rat (HLR). St Marianna Med J 22: 958-960 (1994)
10. Tanaka, M., C. Matsumoto, T. Kumai, M. Watanabe, C. Sekine, S. Kobayashi: Effect of ebselen on plasma cholesterol, triglyceride and lipoprotein. St Marianna Med J 22: 261-268 (1994)
11. Watanabe, M., H. Nakura, T. Tateishi, M. Tanaka, T. Kumai, S. Kobayashi: Reduced hepatic drug-metabolizing enzyme activities in spontaneously hyperlipidemic rats as a model of hypercholesterolemia. Med Sci Res 24: 257-259 (1996)
12. Dietschy, J. M., J. D. Wilson: Regulation of cholesterol metabolism. N Engl J Med 282: 1128-1138 (1970)
13. Brassil, P. J., R. J. Edwards, D. S. Davies: Expression and distribution of cholesterol 7α-hydroxylase in rat liver. Biochem Pharmacol 50: 311-316 (1995)
14. Jelinek, D. F., S. Anderson, C. A. Slaughter, D. W. Russell: Cloning and regulation of cholesterol 7α-hydroxylase, the rate-limiting enzyme in bile acid biosynthesis. J Biol Chem 265: 8190-8197 (1990)
15. th International Symposium on Microsomes and Drug Oxidations (abstracts) pp164 (1996)
16. Garcia, M. J., P. M. McNamara, T. Gordon, W. B. Kannes: Morbidity and mortality in diabetics in the framingham population. Diabetes 23: 105-111 (1974)
17. Steinberg, D., S. Parthasarathy, T. E. Carew, J. C. Khoo, J. L. Witztum: Beyond cholesterol-modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320: 915-924 (1989)
18. Nikkila, E. A., H. K. Huttunen, C. Ehnholm: Postheparin plasma lipoprotein lipase and hepatic lipase in diabetic mellitus. Diabetes 26: 11-21 (1977)
19. Witztum, J. L., E. M. Mahoney, M. J. Branks, M. Fisher, R. Elam, D. Steinberg: Nonenzymatic glucosylation of low-density lipoprotein alters its biologic activity. Diabetes 31: 283-291 (1982)
20. Lorenzi, M., E. Cagliero, B. Markey, T. Henriksen, J. L. Witztum, T. Sampietro: Interaction of human endothelial cell with elevated glucose concentrations and native and glucosylated low density lipoproteins. Diabetologia 26: 218-222 (1984)
21. Kesaniemi, Y. A., J. L. Witztum, U. P. Steinbrecher: Receptor-mediated catabolism of low density lipoprotein in man. J Clin Invest 71: 950-959 (1983)
22. Steinbrecher, UP, J. L. Witztum: Glucosilation of low-density lipoproteins to an extent comparable to that seen in diabetes allows their catabolism. Diabetes 33: 130- 134 (1984)
23. Uchida, K., H. Takase, Y. Nomura, Y. Nakamura, H. Igimi, N. Takasu, H. Kurihara, N. Takeuchi: Development of atherosclerosis in alloxan diabetic rats. J Atheroscler Thromb 1: 118-128 (1994)